Search Results - "Lord, Kevin"

Refine Results
  1. 1

    Neurological Complications of COVID-19: Underlying Mechanisms and Management by Shehata, Ghaydaa A, Lord, Kevin C, Grudzinski, Michaela C, Elsayed, Mohamed, Abdelnaby, Ramy, Elshabrawy, Hatem A

    “…COVID-19 is a severe respiratory disease caused by the newly identified human coronavirus (HCoV) Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)…”
    Get full text
    Journal Article
  2. 2

    Cardiac fibroblast-dependent extracellular matrix accumulation is associated with diastolic stiffness in type 2 diabetes by Hutchinson, Kirk R, Lord, C Kevin, West, T Aaron, Stewart, Jr, James A

    Published in PloS one (21-08-2013)
    “…Cardiovascular complications are a leading cause of death in patients with type 2 diabetes mellitus (T2DM). Diastolic dysfunction is one of the earliest…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Mesenteric resistance arteries in type 2 diabetic db/db mice undergo outward remodeling by Souza-Smith, Flavia M, Katz, Paige S, Trask, Aaron J, Stewart, Jr, James A, Lord, Kevin C, Varner, Kurt J, Vassallo, Dalton V, Lucchesi, Pamela A

    Published in PloS one (04-08-2011)
    “…Resistance vessel remodeling is controlled by myriad of hemodynamic and neurohormonal factors. This study characterized structural and molecular remodeling in…”
    Get full text
    Journal Article
  5. 5

    Temporal pattern of left ventricular structural and functional remodeling following reversal of volume overload heart failure by HUTCHINSON, Kirk R, GUGGILAM, Anuradha, CISMOWSKI, Mary J, GALANTOWICZ, Maarten L, WEST, Thomas A, STEWART, James A, XIAOJIN ZHANG, LORD, Kevin C, LUCCHESI, Pamela A

    Published in Journal of applied physiology (1985) (01-12-2011)
    “…Current surgical management of volume overload-induced heart failure (HF) leads to variable recovery of left ventricular (LV) function despite a return of LV…”
    Get full text
    Journal Article
  6. 6

    Oxidative stress contributes to methamphetamine-induced left ventricular dysfunction by Lord, Kevin C., Shenouda, Sylvia K., McIlwain, Elizabeth, Charalampidis, Dimitrios, Lucchesi, Pamela A., Varner, Kurt J.

    Published in Cardiovascular research (01-07-2010)
    “…Aims Our aim was to test the hypothesis that the repeated, binge administration of methamphetamine would produce oxidative stress in the myocardium leading to…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Activator of G Protein Signaling 3 Null Mice: I. Unexpected Alterations in Metabolic and Cardiovascular Function by Blumer, Joe B, Lord, Kevin, Saunders, Thomas L, Pacchioni, Alejandra, Black, Cory, Lazartigues, Eric, Varner, Kurt J, Gettys, Thomas W, Lanier, Stephen M

    Published in Endocrinology (Philadelphia) (01-08-2008)
    “…Activator of G protein signaling (AGS)-3 plays functional roles in cell division, synaptic plasticity, addictive behavior, and neuronal development. As part of…”
    Get full text
    Journal Article
  9. 9

    Electronic tongue for pharmaceutical analytics: quantification of tastes and masking effects by Legin, Andrey, Rudnitskaya, Alisa, Clapham, David, Seleznev, Boris, Lord, Kevin, Vlasov, Yuri

    Published in Analytical and bioanalytical chemistry (01-09-2004)
    “…The organoleptic aspects of pharmaceutical formulations affect their acceptability to the patient and hence can have an important effect on concordance with…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Ecstasy produces left ventricular dysfunction and oxidative stress in rats by Shenouda, Sylvia K., Lord, Kevin C., McIlwain, Elizabeth, Lucchesi, Pamela A., Varner, Kurt J.

    Published in Cardiovascular research (01-09-2008)
    “…Aims Our aim was to determine whether the repeated, binge administration of 3,4-methylenedioxymethamphetamine (ecstasy; MDMA) produces structural and/or…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Changes in cardiovascular responsiveness and cardiotoxicity elicited during binge administration of Ecstasy by Badon, Lisa A, Hicks, Alissa, Lord, Kevin, Ogden, Brian A, Meleg-Smith, Suzanne, Varner, Kurt J

    “…The recreational use of 3,4-methylenedioxymethamphetamine (MDMA; Ecstasy) is often characterized by a repeated pattern of frequent drug administrations (binge)…”
    Get more information
    Journal Article
  14. 14

    Reports of the demise of chemotherapy have been greatly exaggerated by Feinberg, Bruce, Kish, Jonathan, Dokubo, Igoni, Wojtynek, Jeff, Lord, Kevin

    Published in The American journal of managed care (01-06-2019)
    “…Does the rapid integration of both targeted and immuno-oncology drugs into treatment guidelines across solid tumors and hematologic malignancies herald the…”
    Get full text
    Journal Article
  15. 15

    Comparative Effectiveness of Palliative Chemotherapy in Metastatic Breast Cancer: A Real‐World Evidence Analysis by Feinberg, Bruce, Kish, Jonathan, Dokubo, Igoni, Wojtynek, Jeff, Gajra, Ajeet, Lord, Kevin

    Published in The oncologist (Dayton, Ohio) (01-04-2020)
    “…Background In the absence of randomized controlled trials, real‐world evidence may aid practitioners in optimizing the selection of therapy for patients with…”
    Get full text
    Journal Article
  16. 16

    Real-World Dosing Patterns of Ruxolitinib in Patients with Polycythemia Vera Who Are Resistant to or Intolerant of Hydroxyurea by Altomare, Ivy, Nguyen, Anna, Parasuraman, Shreekant, Paranagama, Dilan, Kish, Jonathan K., Lord, Kevin, Colucci, Philomena

    Published in Blood (13-11-2019)
    “…Background Polycythemia vera (PV) is a myeloproliferative neoplasm affecting >100,000 people in the United States annually. Patients (pts) with PV are at risk…”
    Get full text
    Journal Article
  17. 17

    Real-World Dosing Patterns of Ruxolitinib in Patients With Polycythemia Vera Who Are Resistant to or Intolerant of Hydroxyurea by Altomare, Ivy, Parasuraman, Shreekant, Paranagama, Dilan, Kish, Jonathan, Lord, Kevin, Yu, Jingbo, Colucci, Philomena

    Published in Clinical lymphoma, myeloma and leukemia (01-11-2021)
    “…•About 1 in 4 patients with polycythemia vera become resistant and/or intolerant to hydroxyurea.•Ruxolitinib is the only FDA-approved polycythemia vera…”
    Get full text
    Journal Article
  18. 18

    Real-world evidence evaluating the use of single versus combination chemotherapy in salvage therapy for metastatic breast cancer by Feinberg, Bruce A., Lord, Kevin, Kish, Jonathan, Laney, Jalyna R., Chopra, Dhruv, Liassou, Djibril

    Published in Journal of clinical oncology (20-05-2019)
    “…Abstract only e12600 Background: Metastatic breast cancer (mBC) patients often receive multiple lines of systemic chemotherapy (Chemo) to extend life, manage…”
    Get full text
    Journal Article
  19. 19

    Real-world evidence evaluating the use of an NK-1 antiemetic in the systemic chemotherapy treatment of metastatic breast cancer by Lord, Kevin, Feinberg, Bruce A., Kish, Jonathan, Laney, Jalyna R., Chopra, Dhruv, Liassou, Djibril

    Published in Journal of clinical oncology (20-05-2019)
    “…Abstract only e12599 Background: Severe and persistent nausea and vomiting (n/v) impacts quality of life and may lead to treatment discontinuation. While…”
    Get full text
    Journal Article
  20. 20

    Use of a granulocyte colony-stimulating factor for the prevention of febrile neutropenia in the era of value-based care by Feinberg, Bruce A., Lord, Kevin, Kish, Jonathan, Laney, Jalyna R., Chopra, Dhruv, Liassou, Djibril

    Published in Journal of clinical oncology (20-05-2019)
    “…Abstract only e12601 Background: Value based care design is intended to encourage responsible use of medical resources to optimize cost effective delivery of…”
    Get full text
    Journal Article